Ahmed, Muhammad S, Jacques, Laura C, Mahallawi, Waleed H, Ferrara, Francesca, Temperton, Nigel J., Upile, Nav, Vaughan, Casey, Sharma, Ravi, Beer, Helen, Hoschler, Katja, and others. (2014) Cross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection. Antiviral Research, 114 . pp. 106-112. ISSN 0166-3542. (doi:10.1016/j.antiviral.2014.12.008) (Access to this publication is currently restricted. You may be able to access a copy if URLs are provided) (KAR id:46067)
PDF
Author's Accepted Manuscript
Language: English Restricted to Repository staff only |
|
|
|
Official URL: http://dx.doi.org/10.1016/j.antiviral.2014.12.008 |
Abstract
2009 H1N1 pandemic influenza (A(H1N1)pdm09) virus infected large numbers of people worldwide. Recent studies suggest infection with A(H1N1)pdm09 virus elicited cross-reactive anti-hemagglutinin (HA) memory B cell response to conserved regions of HA. However, the breadth and magnitude of cross-reactive immunity in children and adults following A(H1N1)pdm09 infection are unknown. Methods: We investigated serum anti-HA immunity to a number of group-1 and -2 viruses in children and adults using hemagglutination inhibition (HAI), enzyme-linked immunosorbent assay and virus neutralization assay. Results: Applying hemagglutination inhibition (HAI) titres?40 against A(H1N1)pdm09 as threshold of sero-positivity, we observed significantly higher levels of anti-HA antibodies to a number of virus subtypes, including those neutralizing H5N1, in subjects with HAI titre?40 than those with HAI<40. Adults demonstrated broader and stronger cross-reactive anti-HA antibodies than children, including cross-reactive anti-HA1 and -HA2 antibodies. By comparison, individuals with serologic evidence of recent exposure to seasonal H1N1 or H3N2 did not show such broad cross-reactive immunity. Conclusion: Our results suggest individuals exposed to A(H1N1)pdm09 virus developed a broad and age-associated cross-reactive anti-HA immunity which may have important implications for future vaccination strategies to enable protection against a broader range of influenza viruses.
Item Type: | Article |
---|---|
DOI/Identification number: | 10.1016/j.antiviral.2014.12.008 |
Uncontrolled keywords: | Influenza virus; Pandemic H1N1 infection; Serum antibody; Cross-reactive immunity; Anti-hemagglutinin antibody; Virus neutralization |
Subjects: | Q Science > QR Microbiology > QR355 Virology |
Divisions: | Divisions > Division of Natural Sciences > Medway School of Pharmacy |
Depositing User: | Nigel Temperton |
Date Deposited: | 14 Dec 2014 21:20 UTC |
Last Modified: | 05 Nov 2024 10:29 UTC |
Resource URI: | https://kar.kent.ac.uk/id/eprint/46067 (The current URI for this page, for reference purposes) |
- Export to:
- RefWorks
- EPrints3 XML
- BibTeX
- CSV
- Depositors only (login required):